最新报道:According to a report by Bijie.com, Nasdaq-listed Solana treasury company Artelo Biosciences announced the issuance of 640,924 shares of common stock to the public at a price of US$4.40 per share, raising a total of approximately US$3 million. Artelo Biosciences is a clinical pharmaceutical company that has previously announced the official launch of its Solana-based digital asset treasury strategy and will invest part of its capital in the purchase of SOL tokens. As of now, it holds 45,883 SOL tokens.